| P50 | author | Piergiorgio Duca | Q30448311 |
| | Nicola Montano | Q33308512 |
| P2093 | author name string | Giuseppina Pisano | |
| | Ilaria Bossi | |
| | Mara Bulgheroni | |
| | Giorgio Costantino | |
| | Stefano Guzzetti | |
| | Anna Maria Rusconi | |
| | Monica Solbiati | |
| | Raffaello Furlan | |
| | Marta Del Medico | |
| P2860 | cites work | Trends in prevalence and outcome of heart failure with preserved ejection fraction | Q28252937 |
| | The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 |
| | Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing | Q33761562 |
| | A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure | Q34106793 |
| | Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? | Q34116380 |
| | Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure | Q34218661 |
| | The epidemiology of heart failure | Q34417319 |
| | Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review | Q34610692 |
| | Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure | Q34620874 |
| | ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G | Q36259700 |
| | Heart failure: who we treat versus who we study | Q37099340 |
| | The epidemiology of heart failure: the Framingham Study | Q38512101 |
| | Survival after the onset of congestive heart failure in Framingham Heart Study subjects | Q38512499 |
| | The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group | Q42556789 |
| | Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective | Q44372943 |
| | Mortality trends for 23,505 Medicare patients hospitalized with heart failure in Northeast Ohio, 1991 to 1997. | Q47723548 |
| | Congestive heart failure in the community: trends in incidence and survival in a 10-year period. | Q50539807 |
| | Long-Term Trends in the Incidence of and Survival with Heart Failure | Q57073236 |
| | Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds—the TEMISTOCLE study | Q57628879 |
| | Is the prognosis of heart failure improving? | Q61716867 |
| | Heart failure | Q73397364 |
| | Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure; the OSCUR study. Oucome dello Scompenso Cardiaco in relazione all'Utilizzo delle Risore | Q73643564 |
| | Progress in heart failure Management? Lessons from the real world | Q74269887 |
| | Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995 | Q74269913 |
| | Participation in cancer clinical trials: race-, sex-, and age-based disparities | Q80179103 |
| P433 | issue | 2 | |
| P921 | main subject | heart failure | Q181754 |
| | eligibility criteria | Q114840239 |
| P304 | page(s) | 117-122 | |
| P577 | publication date | 2008-08-09 | |
| P1433 | published in | Internal and emergency medicine | Q26842320 |
| P1476 | title | Eligibility criteria in heart failure randomized controlled trials: a gap between evidence and clinical practice | |
| P478 | volume | 4 | |